These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9540786

  • 21. [Immunoanalytical methods of cyclosporine A determination].
    Safarcík K, Komzáková I, Bartos V, Grundmann M.
    Ceska Slov Farm; 2002 May; 51(3):112-20. PubMed ID: 12058351
    [Abstract] [Full Text] [Related]

  • 22. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
    Khoschsorur G, Fruehwirth F, Zelzer S, Stettin M, Halwachs-Baumann G.
    Clin Chim Acta; 2007 May 01; 380(1-2):217-21. PubMed ID: 17320846
    [Abstract] [Full Text] [Related]

  • 23. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
    Assan R, Blanchet F, Feutren G, Timsit J, Larger E, Boitard C, Amiel C, Bach JF.
    Diabetes Metab Res Rev; 2002 May 01; 18(6):464-72. PubMed ID: 12469360
    [Abstract] [Full Text] [Related]

  • 24. Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients.
    Cauduro RL, Costa C, Lhulier F, Garcia RG, Cabral RD, Gonçalves LF, Manfro RC.
    Clin Transplant; 2005 Aug 01; 19(4):470-4. PubMed ID: 16008590
    [Abstract] [Full Text] [Related]

  • 25. The measurement of whole blood pre-treatment cyclosporine A: metabolite ratios predicts the onset of renal dysfunction in recipients of allogeneic stem cell transplantation.
    Stephens E, Bolderson I, Clark B, Kinsey S, Gooi HC, Cook G.
    Ann Clin Biochem; 2006 Sep 01; 43(Pt 5):382-8. PubMed ID: 17022881
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic monitoring of cyclosporine in kidney transplantation: the Halifax experience.
    Singh D, Kiberd B, Belitsky P, Fraser A, Balbontin F, Lawen J.
    Transplant Proc; 2004 Mar 01; 36(2 Suppl):414S-419S. PubMed ID: 15041377
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients.
    Salm P, Warnholtz C, Boyd J, Arabshahi L, Marbach P, Taylor PJ.
    Clin Biochem; 2006 Jul 01; 39(7):732-8. PubMed ID: 16725133
    [Abstract] [Full Text] [Related]

  • 28. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R, Saito S, Ikeda K, Hirano T, Yanase T, Nakashima K, Fujimi S.
    Clin Transplant; 1999 Jul 01; 13 Suppl 1():54-8. PubMed ID: 10751058
    [Abstract] [Full Text] [Related]

  • 29. C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients.
    Ferraresso M, Citterio F, Ghio L, Romagnoli J, Edefonti A, Berardinelli L, Castagneto M.
    Transplant Proc; 2004 Nov 01; 36(9):2656-8. PubMed ID: 15621115
    [Abstract] [Full Text] [Related]

  • 30. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E.
    Pol Merkur Lekarski; 2005 Feb 01; 18(104):168-72. PubMed ID: 17877123
    [Abstract] [Full Text] [Related]

  • 31. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
    Sugioka N, Kokuhu T, Okamoto M, Yoshimura N, Ito Y, Shibata N, Takada K.
    J Pharm Pharmacol; 2006 Sep 01; 58(9):1193-200. PubMed ID: 16945177
    [Abstract] [Full Text] [Related]

  • 32. Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters.
    Takeuchi H, Okuyama K, Konno O, Jojima Y, Akashi I, Nakamura Y, Iwamoto H, Hama K, Iwahori T, Uchiyama M, Ashizawa T, Matsuno N, Nagao T, Hirano T, Oka K.
    Transplant Proc; 2005 May 01; 37(4):1745-7. PubMed ID: 15919452
    [Abstract] [Full Text] [Related]

  • 33. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E, Delucchi MA, Cano F, Valdebenito S, Castillo MC, Villegas R.
    Transplant Proc; 2005 Oct 01; 37(8):3354-7. PubMed ID: 16298594
    [Abstract] [Full Text] [Related]

  • 34. Therapeutic drug monitoring of cyclosporine: 20 years of progress.
    Kahan BD.
    Transplant Proc; 2004 Mar 01; 36(2 Suppl):378S-391S. PubMed ID: 15041372
    [Abstract] [Full Text] [Related]

  • 35. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS, Taylor PJ, Salm P, Morris RG.
    Ther Drug Monit; 2007 Oct 01; 29(5):584-91. PubMed ID: 17898648
    [Abstract] [Full Text] [Related]

  • 36. Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry.
    Ceglarek U, Lembcke J, Fiedler GM, Werner M, Witzigmann H, Hauss JP, Thiery J.
    Clin Chim Acta; 2004 Aug 16; 346(2):181-90. PubMed ID: 15256319
    [Abstract] [Full Text] [Related]

  • 37. [Measuring cyclosporine levels in whole blood in kidney transplantation].
    Bottini PV, Alves-Cunha FA, Moda MA, Souza MI, Garlipp CR.
    Rev Assoc Med Bras (1992); 1998 Aug 16; 44(3):176-8. PubMed ID: 9755544
    [Abstract] [Full Text] [Related]

  • 38. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B, Taieb F, Conti F, Abbas H, Seydi I, Harcouet L, Dauphin A, Calmus Y, Tod M.
    Liver Transpl; 2008 Dec 16; 14(12):1745-51. PubMed ID: 19025918
    [Abstract] [Full Text] [Related]

  • 39. [Cyclosporin-A therapy in autoimmune diseases].
    Patakfalvi A.
    Orv Hetil; 1996 Sep 01; 137(35):1921-7. PubMed ID: 8927346
    [Abstract] [Full Text] [Related]

  • 40. C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients.
    Diciolla F, Scolletta S, Berti L, Maccherini M, Federici D, Bernazzali S, Lisi G, Chiavarelli M.
    Transplant Proc; 2005 Mar 01; 37(2):1355-9. PubMed ID: 15848719
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.